Skip to main content
SpringerLink
Log in

Cervix

  • Chapter
Cancer Precursors

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ries LAG, Eisner MP, Kosary CL, et al. (eds) Cancer Statistics Review, 1973–1997, Bethesda, MD: National Cancer Institute, 2000.

    Google Scholar 

  2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827–41.

    Google Scholar 

  3. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 1993; 54:594–606.

    PubMed  CAS  Google Scholar 

  4. Ferlay J, Parkin DM, Pisani P. GLOBOCAN: cancer incidence and mortality worldwide. International Agency for Research on Cancer (IARC) Cancer Base 3. Lyon, International Agency for Research on Cancer, 1998.

    Google Scholar 

  5. Muir C, Waterhouse J, Mack T, et al. Cancer incidence in five continents, Vol. V. IARC Scientific Publications No. 88, International Agency for Research on Cancer: Lyon, 1987.

    Google Scholar 

  6. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18–29.

    PubMed  CAS  Google Scholar 

  7. CDC. Results from the National Breast and Cervical Cancer Early Detection Program, October 31, 1991–September 30, 1993. MMWR 1994; 43:530–4.

    Google Scholar 

  8. Papanicolaou GN. Atlas of exfoliative cytology. Cambridge, MA: Harvard University Press, 1954.

    Google Scholar 

  9. Reagan JW, Seidemann IL, Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix. Cancer 1953; 6:224–35.

    PubMed  CAS  Google Scholar 

  10. Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968; 5:748–84.

    Google Scholar 

  11. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990; 75:131–3.

    PubMed  CAS  Google Scholar 

  12. Solomon D. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, USA, December, 12–13, 1988. Acta Cytol 1989; 33:567–74.

    Google Scholar 

  13. Kurman RJ, Malkasian GD Jr, Sedlis A, et al. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol 1991; 77:779–82.

    PubMed  CAS  Google Scholar 

  14. National Cancer Institute Workshop. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29–30, 1991. Acta Cytol 1993; 37:115–24.

    Google Scholar 

  15. Meisels A, Morin C. Cytopathology of the uterus, 2nd ed. Chicago: ASCP Press, 1997.

    Google Scholar 

  16. Lawson HW, Lee NC, Thames SF, et al. Cervical cancer screening among low-income women: results of a national screening program, 1991–1995. Obstet Gynecol 1998; 92:745–52.

    Article  PubMed  CAS  Google Scholar 

  17. Bjorge T, Gunbjorud AB, Langmark F, et al. Cervical mass screening in Norway-510,000 smears a year. Cancer Detect Prev 1994; 18:463–70.

    PubMed  CAS  Google Scholar 

  18. Dietl J, Semm K, Hedderich J, et al. CIN and preclinical cervical carcinoma. A study of morbidity trends over a 10-year period. Int J Gynaecol Obstet 1983; 21:283–9.

    Article  PubMed  CAS  Google Scholar 

  19. Learmonth GM, Durcan CM, Beck JD. The changing incidence of cervical intra-epithelial neoplasia. S Afr Med J 1990; 77:637–9.

    PubMed  CAS  Google Scholar 

  20. Utagawa ML, Pereira SM, Cavaliere MJ, et al. Cervical intraepithelial neoplasia in adolescents: study of cytological findings between 1987 and 1995 in Sao Paulo State-Brazil. Arch Gynecol Obstet 1998; 262:59–64.

    Article  PubMed  CAS  Google Scholar 

  21. Sigurdsson K. Trends in cervical intra-epithelial neoplasia in Iceland through 1995: evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol Scand 1999; 78:486–92.

    PubMed  CAS  Google Scholar 

  22. Stern E, Neely PM. Dysplasia of the uterine cervix: incidence of regression, recurrence, and cancer. Cancer 1964; 17:508–12.

    PubMed  CAS  Google Scholar 

  23. Peritz E, Ramcharan S, Frank J, et al. The incidence of cervical cancer and duration of oral contraceptive use. Am J Epidemiol 1977; 106:462–9.

    PubMed  CAS  Google Scholar 

  24. Parkin DM, Hodgson P, Clayden AD. Incidence and prevalence of preclinical carcinoma of cervix in a British population. Br J Obstet Gynaecol 1982; 89:564–70.

    PubMed  CAS  Google Scholar 

  25. Chow WH, Greenberg RS, Liff JM. Decline in the incidence of carcinoma in situ of the cervix. Am J Public Health 1986; 76:1322–4.

    PubMed  CAS  Google Scholar 

  26. Anderson GH, Boyes DA, Benedet JL, et al. Organisation and results of the cervical cytology screening programme in British Columbia, 1955–85. Br Med J 1988; 296:975–8.

    CAS  Google Scholar 

  27. Miller AB, Knight J, Narod S. The natural history of cancer of the cervix, and the implications for screening policy. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. Cambridge (UK): Cambridge Press, 1991, pp. 141–52.

    Google Scholar 

  28. Friedell GH, Tucker TC, McManmon E, et al. Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst 1992; 84:1030–2.

    PubMed  CAS  Google Scholar 

  29. Gram IT, Macaluso M, Churchill J, et al. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 1992; 3:231–6.

    Article  PubMed  CAS  Google Scholar 

  30. Kainz C, Gitsch G, Heinzl H, et al. Incidence of cervical smears indicating dysplasia among Austrian women during the 1980s. Br J Obstet Gynaecol 1995; 102:541–4.

    PubMed  CAS  Google Scholar 

  31. New Zealand Contraception and Health Study Group. An attempt to estimate the incidence of cervical dysplasia in a group of New Zealand women using contraception. Epidemiology 1995; 6:121–6.

    Google Scholar 

  32. Morrison BJ, Coldman AJ, Boyes DA, et al. Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer 1996; 74:814–19.

    PubMed  CAS  Google Scholar 

  33. Bos AB, van Ballegooijen M, van Oortmarssen GJ, et al. Nonprogression of cervical intraepithelial neoplasia estimated from population-screening data. Br J Cancer 1997; 75:124–30.

    PubMed  CAS  Google Scholar 

  34. Forsmo S, Buhaug H, Skjeldestad FE, et al. Treatment of pre-invasive conditions during opportunistic screening and its effectiveness on cervical cancer incidence in one Norwegian county. Int J Cancer 1997; 71:4–8.

    Article  PubMed  CAS  Google Scholar 

  35. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999; 81: 159–66.

    PubMed  CAS  Google Scholar 

  36. Blohmer JU, Schmalisch G, Klette I, et al. Increased incidence of cervical intraepithelial neoplasia in young women in the Mitte district, Berlin, Germany. Acta Cytol 1999; 43:195–200.

    PubMed  CAS  Google Scholar 

  37. Quinn M, Babb P, Jones J, et al. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. Brit Med J 1999; 318:904–8.

    PubMed  CAS  Google Scholar 

  38. Kibur M, Geijerstamm V, Pukkala E, et al. Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination. Sex Transm Infect 2000; 76:13–17.

    PubMed  CAS  Google Scholar 

  39. Sawaya GF, Kerlikowske K, Lee NC, et al. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol 2000; 96:219–23.

    PubMed  CAS  Google Scholar 

  40. Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictive value of cervical smears in previously screened postmenopausal women: The Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med 2000; 133:942–50.

    PubMed  CAS  Google Scholar 

  41. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program. Available from: URL: http://www-seer.ims.nci.nih.gov/

  42. Östor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12:186–92.

    PubMed  Google Scholar 

  43. Mitchell MF, Hittelman WN, Hong WK, et al. The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev 1994; 3:619–26.

    PubMed  CAS  Google Scholar 

  44. McIndoe WA, McLean MR, Jones RW, et al. The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 1984; 64:451–8.

    PubMed  CAS  Google Scholar 

  45. Melnikow J, Nuovo J, Willan AR, et al. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 92(4 Pt 2):727–35.

    Article  PubMed  CAS  Google Scholar 

  46. Holowaty P, Miller AB, Rohan T, et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91:252–8.

    Article  PubMed  CAS  Google Scholar 

  47. Harris RW, Brinton LA, Cowdell RH, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer 1980; 42:359–69.

    PubMed  CAS  Google Scholar 

  48. Brock KE, MacLennan R, Brinton LA, et al. Smoking and infectious agents and risk of in situ cervical cancer in Sydney, Australia. Cancer Res 1989; 49:4925–8.

    PubMed  CAS  Google Scholar 

  49. Cuzick J, Singer A, De Stavola BL, et al. Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 1990; 26:684–90.

    PubMed  CAS  Google Scholar 

  50. Parazzini F, La Vecchia C, Negri E, et al. Risk factors for cervical intraepithelial neoplasia. Cancer 1992; 69:2276–82.

    PubMed  CAS  Google Scholar 

  51. Munoz N, Bosch FX, de Sanjose S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2:423–31.

    PubMed  CAS  Google Scholar 

  52. de Vet HC, Sturmans F. Risk factors for cervical dysplasia: implications for prevention. Public Health 1994; 108:241–9.

    PubMed  Google Scholar 

  53. Kjellberg L, Wang Z, Wiklund F, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol 1999; 80:391–8.

    PubMed  CAS  Google Scholar 

  54. Franco EL. Viral etiology of cervical cancer: a critique of the evidence. Rev Infect Dis 1991; 13:1195–206.

    PubMed  CAS  Google Scholar 

  55. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92:690–8.

    Article  PubMed  Google Scholar 

  56. Cox JT. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Baillieres Clin Obstet Gynaecol 1995; 9:1–37.

    PubMed  CAS  Google Scholar 

  57. IARC Working Group. Human papillomaviruses. IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 64. Lyon: International Agency for Research on Cancer, 1995.

    Google Scholar 

  58. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235–40.

    PubMed  CAS  Google Scholar 

  59. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423–8.

    Article  PubMed  CAS  Google Scholar 

  60. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415–23.

    Article  PubMed  CAS  Google Scholar 

  61. Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182:1097–102.

    Article  PubMed  CAS  Google Scholar 

  62. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183:8–15.

    Article  PubMed  CAS  Google Scholar 

  63. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76(10 Suppl):1888–901.

    PubMed  CAS  Google Scholar 

  64. Morrison EA, Ho GY, Vermund SH, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991; 49:6–13.

    PubMed  CAS  Google Scholar 

  65. Van Den Brule AJ, Walboomers JM, Du Maine M, et al. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48:404–8.

    Google Scholar 

  66. Kadish AS, Hagan RJ, Ritter DB, et al. Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. Hum Pathol 1992; 23:1262–9.

    Article  PubMed  CAS  Google Scholar 

  67. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272–8.

    PubMed  CAS  Google Scholar 

  68. Levine AJ, Harper J, Hilborne L, et al. HPV DNA and the risk of squamous intraepithelial lesions of the uterine cervix in young women. Am J Clin Pathol 1993; 100:6–11.

    PubMed  CAS  Google Scholar 

  69. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958–64.

    PubMed  CAS  Google Scholar 

  70. Bosch FX, Munoz N, de Sanjose S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2:415–22.

    PubMed  CAS  Google Scholar 

  71. Becker TM, Wheeler CM, McPherson RS, et al. Risk factors for cervical dysplasia in southwestern American Indian women: a pilot study. Alaska Med 1993; 35:255–63.

    PubMed  CAS  Google Scholar 

  72. Coker AL, Jenkins GR, Busnardo MS, et al. Human papillomaviruses and cervical neoplasia in South Carolina. Cancer Epidemiol Biomarkers Prev 1993; 2:207–12.

    PubMed  CAS  Google Scholar 

  73. Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 1994; 271:1181–8.

    Article  PubMed  CAS  Google Scholar 

  74. Brisson J, Morin C, Fortier M, et al. Risk factors for cervical intraepithelial neoplasia: differences between low-and high-grade lesions. Am J Epidemiol 1994; 140:700–10.

    PubMed  CAS  Google Scholar 

  75. Liaw KL, Hsing AW, Chen CJ, et al. Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer 1995; 62:565–71.

    PubMed  CAS  Google Scholar 

  76. Olsen AO, Gjoen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II–III: a population-based case-control study. Int J Cancer 1995; 61:312–15.

    PubMed  CAS  Google Scholar 

  77. Sasagawa T, Dong Y, Saijoh K, et al. Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan. Jpn J Cancer Res 1997; 88:376–84.

    PubMed  CAS  Google Scholar 

  78. Liaw KL, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999; 91:954–60.

    Article  PubMed  CAS  Google Scholar 

  79. MacLehose RF, Harpster A, Lanier AP, et al. Risk factors for cervical intraepithelial neoplasm in Alaska Native women: a pilot study. Alaska Med 1999; 41:76–85.

    PubMed  CAS  Google Scholar 

  80. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92:464–74.

    Article  PubMed  CAS  Google Scholar 

  81. Schiff M, Becker TM, Masuk M, et al. Risk factors for cervical intraepithelial neoplasia in southwestern American Indian women. Am J Epidemiol 2000; 152:716–26.

    Article  PubMed  CAS  Google Scholar 

  82. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796–802.

    PubMed  CAS  Google Scholar 

  83. Franco EL. Cancer causes revisited: human papillomavirus and cervical neoplasia. J Natl Cancer Inst 1995; 87:779–80.

    PubMed  CAS  Google Scholar 

  84. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328–37.

    PubMed  CAS  Google Scholar 

  85. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20:274–8.

    PubMed  CAS  Google Scholar 

  86. Herrero R. Epidemiology of cervical cancer. J Natl Cancer Inst Monogr 1996; 21:1–6.

    PubMed  Google Scholar 

  87. Holly EA. Cervical intraepithelial neoplasia, cervical cancer, and HPV. Annu Rev Public Health 1996; 17:69–84.

    Article  PubMed  CAS  Google Scholar 

  88. Walboomers JM, Meijer CJ. Do HPV-negative cervical carcinomas exist? J Pathol 1997; 181:253–4

    Article  PubMed  CAS  Google Scholar 

  89. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12–19.

    Article  PubMed  CAS  Google Scholar 

  90. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999; 91:506–11.

    Article  PubMed  CAS  Google Scholar 

  91. Franco EL, Villa LL, Rahal P, et al. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst 1994; 86:1558–9.

    PubMed  CAS  Google Scholar 

  92. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132:277–84.

    PubMed  CAS  Google Scholar 

  93. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365–71.

    PubMed  CAS  Google Scholar 

  94. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61:306–11.

    PubMed  CAS  Google Scholar 

  95. Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996; 69:364–8.

    Article  PubMed  CAS  Google Scholar 

  96. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354:20–5.

    Article  PubMed  CAS  Google Scholar 

  97. Ylitalo N, Josefsson A, Melbye M, et al. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 2000; 60:6027–32.

    PubMed  CAS  Google Scholar 

  98. Winkelstein W Jr. Smoking and cervical cancer-current status: a review. Am J Epidemiol 1990; 131:945–57.

    PubMed  Google Scholar 

  99. Schiffman MH, Haley NJ, Felton JS, et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 1987; 47:3886–8.

    PubMed  CAS  Google Scholar 

  100. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4:415–28.

    PubMed  CAS  Google Scholar 

  101. Lyon JL, Gardner JW, West DW, et al. Smoking and carcinoma in situ of the uterine cervix. Am J Public Health 1983; 73:558–62.

    PubMed  CAS  Google Scholar 

  102. La Vecchia C, Franceschi S, Decarli A, et al. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 1986; 123:22–9.

    PubMed  Google Scholar 

  103. Gram IT, Austin H, Stalsberg H. Cigarette smoking and the incidence of cervical intraepithelial neoplasia, grade III, and cancer of the cervix uteri. Am J Epidemiol 1992; 135:341–6.

    PubMed  CAS  Google Scholar 

  104. Becker TM, Wheeler CM, McGough NS, et al. Cigarette smoking and other risk factors for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 1994; 3:113–19.

    PubMed  CAS  Google Scholar 

  105. de Vet HC, Sturmans F, Knipschild PG. The role of cigarette smoking in the etiology of cervical dysplasia. Epidemiology 1994; 5:631–3.

    PubMed  Google Scholar 

  106. Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998; 78:281–5.

    PubMed  CAS  Google Scholar 

  107. Phillips AN, Smith GD. Cigarette smoking as a potential cause of cervical cancer: has confounding been controlled? Int J Epidemiol 1994; 23:42–9.

    PubMed  CAS  Google Scholar 

  108. Brinton LA, Hamman RF, Huggins GR, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987; 79:23–30.

    PubMed  CAS  Google Scholar 

  109. Brinton LA, Reeves WC, Brenes MM, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989; 130:486–96.

    PubMed  CAS  Google Scholar 

  110. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987; 40:198–201.

    PubMed  CAS  Google Scholar 

  111. Pater MM, Mittal R, Pater A. Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 1994; 2:229–34.

    Article  PubMed  CAS  Google Scholar 

  112. Becker TM, Wheeler CM, McGough NS, et al. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Int J Epidemiol 1994; 23:913–22.

    PubMed  CAS  Google Scholar 

  113. Molina R, Thomas DB, Dabancens A, et al. Oral contraceptives and cervical carcinoma in situ in Chile. Cancer Res 1988; 48:1011–15.

    PubMed  CAS  Google Scholar 

  114. Jones CJ, Brinton LA, Hamman RF, et al. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res 1990; 50:3657–62.

    PubMed  CAS  Google Scholar 

  115. Brinton LA. Epidemiology of cervical cancer-overview. IARC Sci Publ 1992; 119:3–23.

    PubMed  Google Scholar 

  116. Schiffman MH, Brinton LA, Devesa SS, et al. Cervical Cancer. In: Schottenfeld D, Fraumeni JF, Jr. (eds) Cancer epidemiology and prevention. New York: Oxford University Press, 1996, pp. 1090–116.

    Google Scholar 

  117. Irwin KL, Rosero-Bixby L, Oberle MW, et al. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? JAMA 1988; 259:59–64.

    Article  PubMed  CAS  Google Scholar 

  118. Beral V, Hannaford P, Kay C. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners’ Oral Contraception Study. Lancet 1988; 2:1331–5.

    PubMed  CAS  Google Scholar 

  119. Negrini BP, Schiffman MH, Kurman RJ, et al. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res 1990; 50:4670–5.

    PubMed  CAS  Google Scholar 

  120. Gram IT, Macaluso M, Stalsberg H. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1992; 167:40–4.

    PubMed  CAS  Google Scholar 

  121. Coker AL, McCann MF, Hulka BS, et al. Oral contraceptive use and cervical intraepithelial neoplasia. J Clin Epidemiol 1992; 45:1111–18.

    Article  PubMed  CAS  Google Scholar 

  122. Potischman N, Brinton LA. Nutrition and cervical neoplasia. Cancer Causes Control 1996; 7:113–26.

    Article  PubMed  CAS  Google Scholar 

  123. Palan PR, Mikhail MS, Goldberg GL, et al. Plasma levels of b-carotene, lycopene, canthaxanthin, retinol, and α-and τ-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res 1996; 2:181–5.

    PubMed  CAS  Google Scholar 

  124. Giuliano AR. The role of nutrients in the prevention of cervical dysplasia and cancer. Nutrition 2000; 16:570–3.

    Article  PubMed  CAS  Google Scholar 

  125. Brock KE, Berry G, Mock PA, et al. Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst 1988; 80:580–5.

    PubMed  CAS  Google Scholar 

  126. VanEenwyk J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 1991; 48:34–8.

    PubMed  CAS  Google Scholar 

  127. VanEenwyk J, Davis FG, Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1992; 1:119–24.

    PubMed  CAS  Google Scholar 

  128. Liu T, Soong SJ, Wilson NP, et al. A case control study of nutritional factors and cervical dysplasia. Cancer Epidemiol Biomarkers Prev 1993; 2:525–30.

    PubMed  CAS  Google Scholar 

  129. Kwasniewska A, Charzewska J, Tukendorf A, et al. Dietary factors in women with dysplasia colli uteri associated with human papillomavirus infection. Nutr Cancer 1998; 30:39–45.

    PubMed  CAS  Google Scholar 

  130. Ziegler RG, Jones CJ, Brinton LA, et al. Diet and the risk of in situ cervical cancer among white women in the United States. Cancer Causes Control 1991; 2:17–29.

    Article  PubMed  CAS  Google Scholar 

  131. de Vet HC, Knipschild PG, Grol ME, et al. The role of b-carotene and other dietary factors in the aetiology of cervical dysplasia: results of a case-ontrol study. Int J Epidemiol 1991; 20:603–10.

    PubMed  Google Scholar 

  132. Palan PR, Mikhail MS, Basu J, et al. Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 1991; 15:13–20.

    PubMed  CAS  Google Scholar 

  133. Cuzick J, De Stavola BL, Russell MJ, et al. Vitamin A, vitamin E and the risk of cervical intraepithelial neoplasia. Br J Cancer 1990; 62:651–2.

    PubMed  CAS  Google Scholar 

  134. Kwasniewska A, Tukendorf A, Semczuk M. Content of α-tocopherol in blood serum of human Papillomavirus-infected women with cervical dysplasias. Nutr Cancer 1997; 28:248–51.

    PubMed  CAS  Google Scholar 

  135. Kwasniewska A, Tukendorf A, Semczuk M. Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 1997; 18:526–30.

    PubMed  CAS  Google Scholar 

  136. Liu T, Soong SJ, Alvarez RD, et al. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression. Cancer Epidemiol Biomarkers Prev 1995; 4:373–80.

    PubMed  CAS  Google Scholar 

  137. Breitburd F, Ramoz N, Salmon J, et al. HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 1996; 7:359–71.

    Article  PubMed  CAS  Google Scholar 

  138. Odunsi KO, Ganesan TS. The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer. Clin Oncol (R Coll Radiol) 1997; 9:4–13.

    CAS  Google Scholar 

  139. Odunsi K, Terry G, Ho L, et al. Association between HLA DQB1 * 03 and cervical intraepithelial neoplasia. Mol Med 1995; 1:161–71.

    PubMed  CAS  Google Scholar 

  140. Odunsi K, Terry G, Ho L, et al. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer 1996; 67:595–602.

    Article  PubMed  CAS  Google Scholar 

  141. Hildesheim A, Schiffman M, Scott DR, et al. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 1998; 7:1035–41.

    PubMed  CAS  Google Scholar 

  142. Maciag PC, Schlecht NF, Souza PS, et al. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000; 9:1183–91.

    PubMed  CAS  Google Scholar 

  143. Apple RJ, Erlich HA, Klitz W, et al. HLA DRDQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet 1994; 6:157–62.

    Article  PubMed  CAS  Google Scholar 

  144. Apple RJ, Becker TM, Wheeler CM, et al. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 1995; 87:427–36.

    PubMed  CAS  Google Scholar 

  145. Sanjeevi CB, Hjelmstrom P, Hallmans G, et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 1996; 68:409–14.

    Article  PubMed  CAS  Google Scholar 

  146. Helland A, Olsen AO, Gjoen K, et al. An increased risk of cervical intra-epithelial neoplasia grade II–III among human papillomavirus positive patients with the HLADQA1* 0102–DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 1998; 76:19–24.

    Article  PubMed  CAS  Google Scholar 

  147. CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-C17):1–19.

    Google Scholar 

  148. Wright TC, Jr. Papillomavirus infection and neoplasia in women infected with human immunodeficiency virus. In: Franco EL, Monsonego J (eds) New developments in cervical cancer screening and prevention. Oxford: Blackwell Science, 1997, pp. 131–43.

    Google Scholar 

  149. Jay N, Moscicki AB. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Reader 2000; 10:659–68.

    PubMed  CAS  Google Scholar 

  150. Langley CL, Benga-De E, Critchlow CW, et al. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women. AIDS 1996; 10:413–17.

    PubMed  CAS  Google Scholar 

  151. Rezza G, Giuliani M, Branca M, et al. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol 1997; 13:937–43.

    Article  PubMed  CAS  Google Scholar 

  152. Maiman M, Fruchter RG, Sedlis A, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998; 68:233–9.

    Article  PubMed  CAS  Google Scholar 

  153. Massad LS, Riester KA, Anastos KM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women’s Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999; 21:33–C41.

    PubMed  CAS  Google Scholar 

  154. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000; 154:127–34.

    PubMed  CAS  Google Scholar 

  155. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283:1031–7.

    Article  PubMed  CAS  Google Scholar 

  156. Mandelblatt JS, Kanetsky P, Eggert L, et al. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 1999; 8:97–106.

    PubMed  CAS  Google Scholar 

  157. Miller AB, Nazeer S, Fonn S, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000; 86:440–7.

    Article  PubMed  CAS  Google Scholar 

  158. Gustafsson L, Sparen P, Gustafsson M, et al. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer 1995; 72:498–505.

    PubMed  CAS  Google Scholar 

  159. World Health Organization. National cancer control programmes: policies and managerial guidelines. Geneva: World Health Organization, 1995.

    Google Scholar 

  160. Miller AB, Chamberlain J, Day NE, et al. Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer. Int J Cancer 1990; 46:761–9.

    PubMed  CAS  Google Scholar 

  161. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Washington, DC: U.S. Department of Health and Human Services, 1996.

    Google Scholar 

  162. Smith RA, Mettlin CJ, Davis KJ, et al. American cancer society guidelines for the early detection of cancer. CA cancer J Clin 2000; 50:34–49.

    PubMed  CAS  Google Scholar 

  163. Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994.

    Google Scholar 

  164. Miller AB, Anderson G, Brisson J, et al. Report of a National Workshop on Screening for Cancer of the Cervix. Can Med Assoc J 1991; 145:1301–25.

    CAS  Google Scholar 

  165. La Vecchia C, Franceschi S, Decarli A, et al. “Pap” smear and the risk of cervical neoplasia quantitative estimates from a case-control study. Lancet 1984; 2:779–82

    PubMed  Google Scholar 

  166. Herrero R, Brinton LA, Reeves WC, et al. Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol 1992; 21:1050–6.

    PubMed  CAS  Google Scholar 

  167. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; 1:1247–9.

    PubMed  CAS  Google Scholar 

  168. Benedet JL, Anderson MB, Matisic JP. A comprehensive program for cervical cancer detection and management. Amer J Obstet Gynecol 1992; 166:1254–9.

    CAS  Google Scholar 

  169. McCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Evidence report/technology assessment No. 5. AHCPR Publication No. 99-E010. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, February 1999.

    Google Scholar 

  170. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention, and role of human papillomavirus infection. Can Med Assoc J 2001; 164:1017–25.

    CAS  Google Scholar 

  171. Koss LG. The papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989; 261:737–43.

    Article  PubMed  CAS  Google Scholar 

  172. McGoogan E. Advantages and limitations of automated screening systems in developing and developed countries. In: Franco EL, Monsonego J (eds) New developments in cervical cancer screening and prevention. London: Blackwell, 1997; pp. 317–22.

    Google Scholar 

  173. Wilbur DC, Prey MU, Miller WM, et al. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice. Acta Cytol 1998; 42:214–20.

    PubMed  CAS  Google Scholar 

  174. Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a populationbased study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999; 87:48–55.

    Article  PubMed  CAS  Google Scholar 

  175. Ferenczy A, Robitaille J, Franco E, et al. Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology. Acta Cytol 1996; 40:1136–42.

    PubMed  CAS  Google Scholar 

  176. Austin RM, Ramzy I. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data. Acta Cytol 1998; 42:178–84.

    PubMed  CAS  Google Scholar 

  177. Stafl A. Cervicography: a new method for cervical cancer detection. Am J Obstet Gynecol 1981; 139:815–25.

    PubMed  CAS  Google Scholar 

  178. Mould TA, Singer A. Adjuvant tests to cytology: cervicography and the polarprobe. In: Franco EL, Monsonego J (eds) New developments in cervical cancer screening and prevention. London: Blackwell, 1997; pp. 406–10.

    Google Scholar 

  179. Nuovo J, Melnikow J, Hutchison B, et al. Is cervicography a useful diagnostic test? A systematic overview of the literature. J Am Board Fam Pract 1997; 10:390–7.

    PubMed  CAS  Google Scholar 

  180. Schneider DL, Herrero R, Bratti C, et al. Cervicography screening for cervical cancer among 8460 women in a high-risk population. Am J Obstet Gynecol 1999; 180(2 Pt 1):290–8.

    Article  PubMed  CAS  Google Scholar 

  181. Sankaranarayanan R, Wesley R, Somanathan T, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 1998; 83:2150–6.

    Article  PubMed  CAS  Google Scholar 

  182. Anonymous. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 1999; 353:869–73.

    Google Scholar 

  183. Denny L, Kuhn L, Pollack A, et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89:826–33.

    Article  PubMed  CAS  Google Scholar 

  184. Manos MM, Ting Y, Wright DK, et al. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7:209–14.

    CAS  Google Scholar 

  185. VanDenBrule AJC, Snijders PJF, Gordijn RLJ, et al. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990; 45:644–9.

    CAS  Google Scholar 

  186. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281:1605–10.

    Article  PubMed  CAS  Google Scholar 

  187. Franco EL, Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities. Am J Obstet Gynecol 1999; 181:382–6.

    PubMed  CAS  Google Scholar 

  188. Anonymous. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000; 92:397–402.

    Google Scholar 

  189. Clavel C, Masure M, Bory JP, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 1999; 80:1306–1.

    Article  PubMed  CAS  Google Scholar 

  190. Cuzick J, Beverley E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81:554–8.

    Article  PubMed  CAS  Google Scholar 

  191. Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000; 92:818–25.

    Article  PubMed  CAS  Google Scholar 

  192. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000; 9:945–51.

    PubMed  CAS  Google Scholar 

  193. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283:87–93.

    Article  PubMed  CAS  Google Scholar 

  194. Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000; 89:529–34.

    PubMed  CAS  Google Scholar 

  195. Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81–6.

    PubMed  Google Scholar 

  196. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000; 83:561–5.

    Article  PubMed  CAS  Google Scholar 

  197. Cuzick J. Human papillomavirus testing for primary cervical cancer screening. JAMA 2000; 283:108–9.

    Article  PubMed  CAS  Google Scholar 

  198. Rozendaal L, Walboomers JM, van der Linden JC, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996; 68:766–9.

    Article  PubMed  CAS  Google Scholar 

  199. Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Can Med Assoc J 2000; 163:513–18.

    CAS  Google Scholar 

  200. Ferenczy A. Management of patients with high grade squamous intraepithelial lesions. Cancer 1995; 76(10 Suppl):1928–33.

    PubMed  CAS  Google Scholar 

  201. Ferenczy A. Optimal management of cervical cancer precursors: high grade lesion. In: Franco EL, Monsonego J (eds) New developments in cervical cancer screening and prevention. London: Blackwell, 1997, pp. 116–21.

    Google Scholar 

  202. Cirisano FD. Management of pre-invasive disease of the cervix. Semin Surg Oncol 1999; 16:222–7.

    Article  PubMed  CAS  Google Scholar 

  203. Meheus A. Prevention of sexually transmitted infections through health education and counselling: a general framework. In: Franco EL, Monsonego J (eds) New developments in cervical cancer screening and prevention. London: Blackwell, 1997; pp. 84–90.

    Google Scholar 

  204. Rock CL, Michael CW, Reynolds RK, et al. Prevention of cervix cancer. Crit Rev Oncol Hematol 2000; 33:169–85.

    PubMed  CAS  Google Scholar 

  205. Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol 1999; 9:431–44.

    Article  PubMed  CAS  Google Scholar 

  206. Schiller JT. Papillomavirus-like particle vaccines for cervical cancer. Mol Med Today 1999; 5:209–15.

    PubMed  CAS  Google Scholar 

  207. Platz CE, Benda JA. Female genital tract cancer. Cancer 1995; 75(1 Suppl):270–94.

    PubMed  CAS  Google Scholar 

  208. Smith HO, Tiffany MF, Qualls CR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24-year population-based study. Gynecol Oncol 2000; 78:97–105.

    Article  PubMed  CAS  Google Scholar 

  209. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75:536–45.

    Article  PubMed  CAS  Google Scholar 

  210. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990; 39:40–6.

    Article  PubMed  CAS  Google Scholar 

  211. Ferenczy A. Glandular lesions: an increasing problem. In: Franco EL, Monsonego J (eds) New developments in cervical cancer screening and prevention. London: Blackwell, 1997; pp. 122–30.

    Google Scholar 

  212. Anton-Culver H, Bloss JD, Bringman D, et al. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Am J Obstet Gynecol 1992; 166:1507–14.

    PubMed  CAS  Google Scholar 

  213. Solomon D, Frable WJ, Vooijs GP, et al. ASCUS and AGUS criteria. International Academy of Cytology Task Force summary. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 1998; 42:16–24.

    PubMed  CAS  Google Scholar 

  214. Gallup DG, Abell MR. Invasive adenocarcinoma of the uterine cervix. Obstet Gynecol 1977; 49:596–603.

    PubMed  CAS  Google Scholar 

  215. Pacey NF. Glandular neoplasms of the uterine cervix. In: Bibbo M (ed) Comprehensive cytopathology. Philadelphia: W.B. Saunders, 1991, 231–256.

    Google Scholar 

  216. Ostor AG, Pagano R, Davoren RA, et al. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984; 3:179–90.

    PubMed  CAS  Google Scholar 

  217. Plaxe SC, Saltzstein SL. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol 1999; 75:55–61.

    Article  PubMed  CAS  Google Scholar 

  218. Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989; 8:321–30.

    PubMed  CAS  Google Scholar 

  219. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989; 8:8–17.

    PubMed  CAS  Google Scholar 

  220. Eddy GL, Ural SH, Strumpf KB, et al. Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda System. Gynecol Oncol 1997; 67:51–5.

    Article  PubMed  CAS  Google Scholar 

  221. Brinton LA, Huggins GR, Lehman HF, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986; 38:399–44.

    Google Scholar 

  222. Kvale G, Heuch I, Nilssen S. Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 1988; 58:820–4.

    PubMed  CAS  Google Scholar 

  223. Parazzini F, La Vecchia C, Negri E, et al. Risk factors for adenocarcinoma of the cervix: a case-control study. Br J Cancer 1988; 57:201–4.

    PubMed  CAS  Google Scholar 

  224. Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990; 19:4–11.

    PubMed  CAS  Google Scholar 

  225. Brinton LA, Herrero R, Reeves WC, et al. Risk factors for cervical cancer by histology. Gynecol Oncol 1993; 51:301–6.

    Article  PubMed  CAS  Google Scholar 

  226. Ursin G, Peters RK, Henderson BE, et al. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994; 344:1390–4.

    Article  PubMed  CAS  Google Scholar 

  227. Lacey JV Jr, Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999; 8:1079–85.

    PubMed  Google Scholar 

  228. Lacey JV Jr, Brinton LA, Barnes WA, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000; 77:149–54.

    Article  PubMed  CAS  Google Scholar 

  229. Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993; 15:486–98.

    PubMed  CAS  Google Scholar 

  230. Taylor HB, Irey NS, Norris HJ. Atypical endocervical hyperplasia in women taking oral contraceptives. JAMA 1967; 202:637–9.

    Article  PubMed  CAS  Google Scholar 

  231. Czernobilsky B, Kessler I, Lancet M. Cervical adenocarcinoma in a woman on long-term contraceptives. Obstet Gynecol 1974; 43:517–21.

    PubMed  CAS  Google Scholar 

  232. Dallenbach-Hellweg G. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract 1984; 179:38–50.

    PubMed  CAS  Google Scholar 

  233. Chumas JC, Nelson B, Mann WJ, et al. Microglandular hyperplasia of the uterine cervix. Obstet Gynecol 1985; 66:406–9.

    PubMed  CAS  Google Scholar 

  234. Ford LC, Berek JS, Lagasse LD, et al. Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva. Gynecol Oncol 1983; 15:27–31.

    PubMed  CAS  Google Scholar 

  235. Pater A, Bayatpour M, Pater MM. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 1990; 162:1099–103.

    PubMed  CAS  Google Scholar 

  236. Potischman N. Nutritional epidemiology of cervical neoplasia. J Nutr 1993; 123:424–9.

    PubMed  CAS  Google Scholar 

  237. Duggan MA, Benoit JL, McGregor SE, et al. Adenocarcinoma in situ of the endocervix: human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification. Int J Gynecol Pathol 1994; 13:143–9.

    PubMed  CAS  Google Scholar 

  238. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995; 85:1017–21.

    Article  PubMed  CAS  Google Scholar 

  239. Hildesheim A, Hadjimichael O, Schwartz PE, et al. Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol 1999; 180:571–7.

    Article  PubMed  CAS  Google Scholar 

  240. Cheng RF, Hernandez E, Anderson LL, et al. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance. J Reprod Med 1999; 44:922–8.

    PubMed  CAS  Google Scholar 

  241. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer 2000; 90:207–14.

    Article  PubMed  CAS  Google Scholar 

  242. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999; 30:816–25.

    Article  PubMed  CAS  Google Scholar 

  243. Nicklin JL, Wright RG, Bell JR, et al. A clinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust N Z J Obstet Gynaecol 1991; 31:179–83.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Eduardo L. Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex Ferenczy
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Oncology and Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  2. Division of Cancer Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  3. Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA

    Thomas E. Rohan MB, BS, PhD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Franco, E.L., Ferenczy, A. (2002). Cervix. In: Franco, E.L., Rohan, T.E. (eds) Cancer Precursors. Springer, New York, NY. https://doi.org/10.1007/0-387-21605-7_17

Download citation

  • DOI: https://doi.org/10.1007/0-387-21605-7_17

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95188-1

  • Online ISBN: 978-0-387-21605-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation